Retracted COVID-19 studies expose holes in vetting of data firms

The US FDA now allows data gathered outside of clinical trials to be considered in its reviews of new drugs, providing another boost to the healthcare analytics industry https://www.jpost.com/international/retracted-covid-19-studies-expose-holes-in-vetting-of-data-firms-630906